CLINICAL_TRIALS
trial_result
· 2025-03-28
Clinical Trial Update: Single-Cell Profiling of Liver-infiltrating Immune Cells of Patients with NASH- and Virus-related HCC: Implications for Immunotherapy
Summary
A completed single-cell profiling study of liver-infiltrating immune cells in hepatocellular carcinoma associated with MASLD or hepatitis C infection. The findi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Hepatocellular Carcinoma (HCC), MASLD-HCC | Status: COMPLETED